Step 1 Respiratory
Respiratory is one of the highest-yield systems on USMLE Step 1. Expect questions on PFT interpretation, hypoxemia mechanisms, obstructive and restrictive diseases, lung cancer paraneoplastic syndromes, pulmonary pharmacology, and neonatal lung pathology. Both standalone physiology questions and clinical vignettes appear regularly — a patient with dyspnea, a neonate in respiratory distress, or a smoker with a pulmonary nodule can each open into a deep mechanistic question. For anyone studying high-yield respiratory topics for Step 1, V/Q mismatch physiology and obstructive versus restrictive PFT patterns are the foundations that support every pulmonary question.
The tricky part is that respiratory physiology is layered: you need lung volumes before PFT patterns, A-a gradient before hypoxemia causes, and V/Q concepts before you can reason through PE or COPD exacerbation. Students consistently confuse shunt and dead space — a shunt is perfusion without ventilation (A-a gradient is elevated and does not correct with supplemental O2), while dead space is ventilation without perfusion. Getting that distinction wrong collapses the entire hypoxemia framework.
Step 1 respiratory pharmacology and pathology questions are often paired — asthma biologics, CFTR modulators, and the COPD management ladder are all high-frequency. Another common misconception: students assume type I pneumocytes produce surfactant, when it is type II pneumocytes that synthesize and secrete it (type I cells handle gas exchange). The embryology and neonatal section (surfactant, RDS, CDH) shows up more than students expect on USMLE respiratory questions, and examiners love swapping Bochdalek vs Morgagni hernias. Lock in the mechanisms, not just the facts.
Lung Development Stages
Five stages of lung development — order, timing, and which stage determines fetal viability.
- Confuses the order or timing of pseudoglandular and canalicular stages
- Misattributes fetal viability to the saccular rather than late canalicular stage
Surfactant Production and Neonatal RDS
Type II pneumocytes, LaPlace's law, and why premature lungs collapse — plus RDS presentation and treatment.
- Attributes surfactant production to type I rather than type II pneumocytes
- Believes surfactant increases rather than decreases surface tension
Bronchopulmonary Dysplasia
Chronic post-RDS lung injury defined at 36 weeks PMA, with simplified alveoli and lung-protective ventilation strategy.
- Confuses BPD as an acute neonatal diagnosis rather than a chronic post-RDS complication defined at 36 weeks PMA
- Expects dense fibrosis in BPD histology rather than simplified alveoli with arrested development
Congenital Diaphragmatic Hernia
Bochdalek vs Morgagni hernias — location, severity, pulmonary hypoplasia, and the scaphoid abdomen clue.
- Confuses Bochdalek and Morgagni hernias in terms of location, side, and clinical severity
- Attributes CDH morbidity solely to mechanical compression rather than to pulmonary hypoplasia and persistent pulmonary hypertension
Airway Branching and Zones
Right mainstem anatomy, body-position-dependent aspiration segments, and where conducting zone ends.
- Does not know why aspirated material preferentially enters the right mainstem bronchus
- Ignores body position when predicting which lung segment receives aspirated material
Alveolar Cells — Type I and Type II Pneumocytes
Gas exchange depends on thin type I cells, while type II cells produce surfactant and regenerate both lineages — and one of them spawns adenocarcinoma.
- Confuses which pneumocyte type covers the majority of alveolar surface area
- Attributes alveolar regenerative capacity to type I rather than type II pneumocytes
Pleura and Diaphragm
Parietal pleura causes pain, phrenic nerve roots C3–C5, and the three diaphragmatic hiatus levels.
- Believes the visceral pleura is pain-sensitive, not recognizing that pleuritic pain originates from the parietal pleura
- Misidentifies the phrenic nerve root origin, omitting C3 and C4
Pulmonary Vasculature and Hypoxic Vasoconstriction
Dual blood supply protects against infarct; hypoxic vasoconstriction helps locally but drives pulmonary hypertension globally.
- Assumes pulmonary embolism routinely causes lung infarction, ignoring the protective dual blood supply
- Incorrectly assumes pulmonary vascular resistance is comparable to systemic resistance
Lung Volumes and Capacities
Definitions, compositions, and which volumes spirometry cannot measure — including why FRC changes with disease.
- Confuses FRC with RV, not recognizing that FRC includes the expiratory reserve volume
- Believes spirometry can directly measure residual volume and total lung capacity
PFT Patterns — Obstructive vs Restrictive
FEV1/FVC ratio, DLCO interpretation, and mapping diseases to obstructive, intrinsic restrictive, or extrinsic restrictive patterns.
- Incorrectly expects a decreased FEV1/FVC ratio in restrictive lung disease
- Expects normal DLCO in emphysema, not recognizing that alveolar destruction reduces diffusing capacity
Lung Compliance and Airway Resistance
Emphysema increases compliance, fibrosis decreases it — and parallel small airways dominate resistance less than expected.
- Confuses emphysema with fibrosis regarding direction of compliance change
- Assumes smallest airways have highest resistance, ignoring parallel arrangement
Alveolar Gas Equation and A-a Gradient
Calculating PAO2, interpreting A-a gradient, and using the 0.8 RQ to localize respiratory failure at the bedside.
- Expects A-a gradient to be zero in a healthy person
- Incorrectly attributes a widened A-a gradient to hypoventilation
Five Causes of Hypoxemia
Five mechanisms of hypoxemia — shunt uniquely fails the 100% O2 challenge while others respond.
- Fails to distinguish shunt from other widened-A-a-gradient causes using the O2 challenge
- Overestimates the role of diffusion limitation as a resting cause of hypoxemia
Oxyhemoglobin Dissociation Curve
Rightward shift increases O2 unloading; CO and methemoglobin fool pulse oximetry and require specific antidotes.
- Confuses decreased O2 affinity (right shift) with increased O2 carrying capacity
- Trusts pulse oximetry to detect carboxyhemoglobin in CO poisoning
CO2 Transport in Blood
Bicarbonate carries 70% of CO2; the Haldane effect and chloride shift link CO2 loading to oxyhemoglobin release.
- Underestimates bicarbonate as the dominant form of CO2 transport
- Confuses the Haldane effect with the Bohr effect
V/Q Matching — Apex vs Base, Dead Space, Shunt
Gravity gives the apex high V/Q and the base low V/Q — explaining TB localization, dead space, and shunt physiology.
- Incorrectly assigns a low V/Q ratio to the lung apex
- Assumes dead space always causes hypercapnia regardless of ventilatory compensation
Control of Breathing
Peripheral chemoreceptors sense hypoxia; central chemoreceptors sense CSF pH — both matter for COPD O2 management.
- Attributes the hypoxic ventilatory response to central rather than peripheral chemoreceptors
- Oversimplifies COPD O2 risk as purely loss of hypoxic drive, leading to withholding needed O2
High-Altitude Physiology
Hyperventilation causes respiratory alkalosis acutely; EPO-driven erythrocytosis and acetazolamide characterize chronic adaptation.
- Incorrectly labels altitude-induced hyperventilation as causing respiratory acidosis
- Misattributes acetazolamide's benefit in altitude sickness to direct O2 effects rather than renal bicarbonate wasting
Asthma
Th2-driven eosinophilic inflammation with Charcot-Leyden crystals, reversible obstruction, and COX-1 blockade underlying AERD.
- Misattributes Curschmann spirals and Charcot-Leyden crystals to COPD rather than asthma
- Misunderstands the COX-1 mechanism of AERD and safety of COX-2 inhibitors
COPD — Emphysema
Centriacinar lesions go upper lobe with smoking; panacinar lesions go lower lobe with α1-AT deficiency.
- Incorrectly localizes centriacinar emphysema to the lower lobes
- Confuses the lower-lobe predominance of panacinar emphysema with the upper-lobe pattern of centriacinar
COPD — Chronic Bronchitis
Productive cough for 3 months over 2 consecutive years, elevated Reid index, and hypoxia-driven cor pulmonale.
- Confuses the 3-month/2-year clinical definition with a single 3-month episode
- Misidentifies what structures the Reid index compares
COPD — Acute Exacerbation
Stepwise bronchodilator and antibiotic therapy, targeting SpO2 88–92% to avoid hypercapnic respiratory failure.
- Targets too-high SpO2 in COPD exacerbation, risking hypercapnic respiratory failure
- Overprescribes antibiotics in AECOPD without applying Anthonisen criteria
COPD — Chronic Management
Smoking cessation and supplemental O2 reduce mortality; inhaler escalation follows GOLD groups before adding ICS.
- Attributes mortality benefit to inhalers rather than smoking cessation and supplemental O2
- Adds ICS too early in COPD management, bypassing the bronchodilator-first approach
Bronchiectasis
Irreversible airway dilation with signet-ring sign on CT — caused by CF, Kartagener syndrome, or ABPA.
- Confuses ground-glass opacities with the signet ring sign as the defining CT feature of bronchiectasis
- Misses female infertility as part of Kartagener syndrome's clinical tetrad
Cystic Fibrosis
ΔF508 causes class II CFTR misfolding, thick mucus plugs airways, and Trikafta corrects the underlying protein defect.
- Misidentifies the primary ion affected by CFTR dysfunction as sodium rather than chloride
- Incorrectly predicts low sweat chloride in CF by confusing secretion with reabsorption in sweat ducts
Alpha-1 Antitrypsin Deficiency
PiZZ homozygotes develop lower-lobe panacinar emphysema and hepatic PAS-positive inclusions from misfolded protein accumulation.
- Mislocates α1-AT emphysema to the upper lobes instead of the lower lobes
- Attributes α1-AT liver disease to deficiency of the protein rather than toxic intracellular accumulation of misfolded protein
Idiopathic Pulmonary Fibrosis
UIP pattern shows temporal heterogeneity and honeycombing; antifibrotics slow progression, but corticosteroids are harmful.
- Misclassifies IPF as obstructive rather than restrictive on PFTs
- Misses the temporal and spatial heterogeneity that distinguishes UIP from other fibrotic patterns
Sarcoidosis
Noncaseating granulomas produce 1-α-hydroxylase, causing hypercalcemia — ACE is elevated but not diagnostic.
- Confuses sarcoidosis granulomas with the caseating granulomas of tuberculosis
- Attributes sarcoid hypercalcemia to PTH excess rather than granuloma-derived 1-α-hydroxylase activity
Pneumoconioses — Silicosis, Asbestosis, CWP, Berylliosis
Silicosis increases TB risk; asbestosis causes lower-lobe fibrosis and synergizes with smoking for lung cancer, not mesothelioma.
- Mislocates asbestosis fibrosis to the upper lobes instead of the lower lobes
- Confuses asbestos-related lung adenocarcinoma risk with the pathognomonic association of asbestos with mesothelioma
Hypersensitivity Pneumonitis
Type III/IV immune reaction to inhaled antigens — antigen avoidance is primary; acute form is reversible, chronic is not.
- Misclassifies HP as IgE-mediated (type I) rather than immune complex and T-cell mediated (types III/IV)
- Fails to distinguish the reversible acute HP presentation from the potentially irreversible fibrotic chronic form
Extrinsic Restrictive Disease
Neuromuscular and chest wall causes reduce lung volumes while preserving DLCO — FVC thresholds guide intubation timing.
- Confuses oxygenation-based triggers with FVC/MIP/MEP thresholds for intubation in neuromuscular failure
- Confuses reduced lung volumes in extrinsic restriction with impaired DLCO, which is actually preserved
Acute Respiratory Distress Syndrome
Berlin criteria require onset within 1 week, bilateral infiltrates, and excluded cardiogenic edema — hyaline membranes form early.
- Misses the 1-week onset criterion in the Berlin definition of ARDS
- Overlooks the requirement to exclude cardiogenic edema when diagnosing ARDS by Berlin criteria
Pulmonary Embolism
Most PEs arise from proximal leg DVTs; hypocapnia from hyperventilation is characteristic, and S1Q3T3 is insensitive.
- Confuses the origin of most PEs, which arise from proximal lower extremity DVT, not upper extremity veins
- Expects hypercapnia in PE due to dead space, but PE characteristically causes hypocapnia from hyperventilation
Deep Vein Thrombosis
Homans sign is unreliable; D-dimer rules out DVT, and anticoagulation duration depends on provoked vs unprovoked status.
- Overvalues Homans sign as a diagnostic test for DVT when it is neither sensitive nor specific
- Confuses D-dimer's role as a rule-out test (high sensitivity) with a rule-in test (low specificity)
Fat and Amniotic Fluid Embolism
Fat embolism appears 24–72 hours post-fracture with hypoxemia, neuro changes, and petechiae; amniotic fluid embolism presents with DIC.
- Expects immediate onset of fat embolism syndrome rather than the characteristic 24–72 hour delay after fracture
- Underemphasizes DIC and cardiovascular collapse as the hallmarks of amniotic fluid embolism, focusing instead on hypoxemia alone
Pulmonary Hypertension (Detail)
Plexiform lesions mark advanced PAH; PCWP on right heart cath distinguishes pre-capillary from post-capillary disease.
- Applies Group 1 PAH vasodilator therapy to all WHO groups of pulmonary hypertension
- Confuses pre-capillary PAH (normal PCWP) with post-capillary pulmonary hypertension (elevated PCWP) on right heart catheterization
Community-Acquired Pneumonia — Typical Organisms
Streptococcus pneumoniae dominates all settings; lobar consolidation vs bronchopneumonia reflects the organism and antibiotic choice follows site of care.
- Reverses the association between lobar pneumonia (S. pneumoniae) and bronchopneumonia (S. aureus, gram-negatives)
- Applies fluoroquinolone monotherapy to ICU CAP when combination beta-lactam plus macrolide/fluoroquinolone is required
Community-Acquired Pneumonia — Atypical Organisms
Mycoplasma causes cold agglutinins; Legionella needs urinary antigen testing and comes from water sources, not birds.
- Expects Legionella to be identified on routine sputum Gram stain when urinary antigen is the preferred rapid diagnostic test
- Confuses the bird-exposure clue for C. psittaci with the water/cooling tower exposure clue for Legionella
Hospital-Acquired and Ventilator-Associated Pneumonia
Onset beyond 48 hours of admission defines HAP; empiric coverage must include MDR gram-negatives and MRSA in high-risk patients.
- Misses the 48-hour threshold that distinguishes HAP from community-acquired pneumonia
- Fails to de-escalate broad HAP/VAP empiric therapy after culture results identify the causative organism and sensitivities
Aspiration Pneumonia and Lung Abscess
Right lower lobe is the dominant site; oral anaerobes predominate and cause putrid sputum with air-fluid levels in abscess.
- Confuses aspiration pneumonia location, which preferentially involves the right lower lobe due to bronchial anatomy
- Underemphasizes oral anaerobes as the dominant pathogens in aspiration pneumonia and lung abscess
Tuberculosis (Primary, Latent, Reactivation)
Primary TB seeds the lower lobe Ghon focus; reactivation targets the upper lobe, and PPD cutoffs are risk-stratified not uniform.
- Confuses Ghon focus, Ghon complex, and Ranke complex as interchangeable terms
- Confuses the lower-lobe predilection of primary TB with the upper-lobe location of reactivation TB
Lung Cancer Overview and Screening
NSCLC outnumbers SCLC; LDCT screening applies to age and pack-year criteria, and calcification pattern predicts nodule behavior.
- Overestimates the frequency of SCLC relative to NSCLC subtypes
- Fails to apply age and pack-year criteria for LDCT screening eligibility
Small Cell Lung Cancer
Central neuroendocrine tumor strongly linked to smoking — produces ectopic ACTH or ADH and causes Lambert-Eaton, not myasthenia.
- Misplaces SCLC as a peripheral tumor rather than a central one
- Confuses ectopic ACTH production in SCLC with pituitary-driven Cushing disease
NSCLC — Adenocarcinoma
Peripheral tumor common in non-smokers, with lepidic growth along alveolar walls and EGFR or ALK driver mutations.
- Incorrectly links adenocarcinoma exclusively to heavy smoking rather than recognizing its non-smoker association
- Misunderstands lepidic growth as invasive rather than non-destructive spread along alveolar walls
NSCLC — Squamous Cell Carcinoma
Central cavitating tumor with keratin pearls secretes PTHrP — PTH is suppressed, distinguishing this from primary hyperparathyroidism.
- Attributes hypercalcemia in squamous cell carcinoma to bone metastases rather than PTHrP secretion
- Expects elevated PTH on lab testing in PTHrP-mediated hypercalcemia
NSCLC — Large Cell Carcinoma
Diagnosis of exclusion after squamous, adeno, and small cell markers are all negative — poor prognosis and peripheral location.
- Expects specific positive markers for large cell carcinoma rather than recognizing it as a diagnosis of exclusion
Local Complications — Pancoast, SVC, Horner
Pancoast tumors compress the sympathetic chain for Horner syndrome; SCLC dominates SVC syndrome; hoarseness means recurrent laryngeal nerve, not direct invasion.
- Misattributes Pancoast-related Horner syndrome to recurrent laryngeal nerve compression rather than sympathetic chain involvement
- Misidentifies the most common cancer causing SVC syndrome as squamous cell rather than SCLC or lymphoma
Bronchial Carcinoid Tumor
Bronchial carcinoids are central, chromogranin-positive, and can cause carcinoid syndrome without liver metastases unlike GI carcinoids.
- Incorrectly assumes carcinoid syndrome from bronchial carcinoid requires liver metastases like GI carcinoids do
- Incorrectly classifies bronchial carcinoid as a completely benign tumor without metastatic risk
Mesothelioma
Asbestos alone drives mesothelioma risk — smoking does not synergize — with a 20–40 year latency and calretinin-positive IHC.
- Incorrectly applies the asbestos-smoking synergy for lung cancer to mesothelioma
- Confuses mesothelioma IHC markers with those of lung adenocarcinoma
Pleural Effusion — Transudate vs Exudate
Light's criteria identify exudates when any one of three ratios is met — chylothorax is triglyceride-rich, not LDH-rich.
- Inverts the logic of Light's criteria, applying the 'any one criterion' rule to transudates instead of exudates
- Misclassifies CHF-related pleural effusion as exudative rather than transudative
Pneumothorax (Primary, Secondary, Tension)
Tension pneumothorax shifts the trachea away from the affected side — treat clinically without waiting for imaging confirmation.
- Confuses primary and secondary spontaneous pneumothorax by assuming both require underlying lung disease
- Confuses direction of tracheal deviation in tension pneumothorax (toward vs. away from affected side)
Obstructive Sleep Apnea
Repetitive upper airway obstruction with continued effort raises cardiovascular and metabolic risk beyond simple daytime sleepiness.
- Confuses obstructive sleep apnea (airway obstruction with effort) with central sleep apnea (absent respiratory drive)
- Underestimates cardiovascular and metabolic complications of untreated OSA beyond daytime somnolence
Epiglottitis
Post-HiB vaccination, adults and immunocompromised patients now predominate — thumb sign on lateral neck X-ray, and never use a tongue depressor.
- Fails to recognize that HiB vaccination has shifted the epidemiology and microbiology of pediatric epiglottitis
- Believes oropharyngeal examination with a tongue depressor is safe and appropriate in suspected epiglottitis
Croup
Parainfluenza virus causes subglottic narrowing and the steeple sign in young children — dexamethasone is primary, epinephrine is rescue.
- Confuses the causative virus of croup (parainfluenza) with that of bronchiolitis (RSV)
- Misattributes the steeple sign to epiglottic pathology rather than subglottic narrowing in croup
Meconium Aspiration Syndrome
Ball-valve obstruction causes air trapping and pneumothorax — routine ET suctioning of vigorous neonates is no longer recommended.
- Applies outdated practice of routine ET suctioning to all meconium-stained deliveries, including vigorous neonates
- Missing understanding of the ball-valve air-trapping mechanism that causes hyperinflation and pneumothorax in meconium aspiration syndrome
β2-Agonists (SABA / LABA)
Bronchodilation via cAMP/PKA relaxes airway smooth muscle — LABAs require concurrent ICS in asthma due to black-box monotherapy warning.
- Confuses β2-agonist mechanism (cAMP/PKA pathway) with direct calcium channel blockade
- Believes LABA monotherapy is acceptable in asthma due to its long duration, ignoring the black box warning requiring concurrent ICS
Inhaled Anticholinergics (SAMA / LAMA)
M3 receptor blockade reduces bronchoconstriction and secretions — LAMAs are first-line COPD maintenance, not asthma.
- Confuses the receptor target of inhaled anticholinergics (muscarinic M3) with β-adrenergic receptors
- Misidentifies LAMAs as first-line maintenance therapy for asthma when they are primarily first-line for COPD
Inhaled and Systemic Corticosteroids
Anti-inflammatory effect in asthma is delayed hours to days; oral candidiasis is the key local ICS toxicity, HPA suppression the systemic one.
- Believes inhaled corticosteroids provide immediate bronchodilation, when their anti-inflammatory effect is delayed by hours to days
- Overestimates systemic toxicity of inhaled corticosteroids and underestimates the importance of local side effects like oral candidiasis
Leukotriene Modifiers
Montelukast blocks receptors; zileuton inhibits 5-lipoxygenase — both are preferred in aspirin-exacerbated respiratory disease with distinct toxicity profiles.
- Confuses the mechanism of receptor antagonists (montelukast, zafirlukast) with the enzyme inhibitor (zileuton) among leukotriene modifiers
- Misses the specific indication of leukotriene modifiers in aspirin-exacerbated respiratory disease (Samter's triad)
Mast Cell Stabilizers and Methylxanthines
Cromolyn prevents mast cell degranulation prophylactically and cannot abort an acute attack; theophylline causes seizures and arrhythmias at toxic levels.
- Believes cromolyn sodium can relieve acute bronchospasm when it is purely a prophylactic mast cell stabilizer
- Misidentifies the primary manifestations of theophylline toxicity, missing seizures and arrhythmias as the most dangerous effects
Biologics for Severe Asthma
Omalizumab targets IgE; mepolizumab targets IL-5 ligand; dupilumab blocks IL-4Rα; tezepelumab targets TSLP for the broadest phenotype coverage.
- Confuses omalizumab's anti-IgE mechanism with anti-IL-5 activity
- Conflates mepolizumab (anti-IL-5 ligand) with benralizumab (anti-IL-5 receptor)
Cystic Fibrosis Drugs
Dornase alfa cleaves DNA to thin mucus; Trikafta combines two correctors and one potentiator for F508del, not G551D.
- Confuses dornase alfa's DNase mechanism with the disulfide-bond-breaking mechanism of N-acetylcysteine
- Reverses the roles of CFTR correctors and potentiators
Mucolytics and Oxygen Therapy
NAC breaks disulfide bonds in mucus and donates glutathione; long-term O2 requires SpO2 ≤88%, and V/Q mismatch is the main O2 risk in COPD.
- Conflates NAC's mucolytic mechanism (disulfide bond cleavage) with its antioxidant role (glutathione precursor)
- Uses an incorrect SpO2 threshold of 92% instead of ≤88% for LTOT indication in COPD
Roflumilast (PDE4 Inhibitor)
PDE4 inhibition raises cAMP in airway cells — indicated only in chronic bronchitis with frequent exacerbations, with neuropsychiatric black-box warning.
- Confuses roflumilast's PDE4 selectivity with PDE3 inhibition used in cardiac drugs like milrinone
- Overgeneralizes roflumilast's indication to all COPD rather than the chronic bronchitis/frequent exacerbation subgroup
Antitussives, Expectorants, and Antihistamines (H1 Blockers)
Dextromethorphan blocks NMDA receptors, not opioid receptors, and causes serotonin syndrome with MAOIs — guaifenesin thins secretions by hydration.
- Incorrectly attributes dextromethorphan's antitussive effect to opioid receptor agonism
- Confuses guaifenesin's hydration-based expectorant mechanism with NAC's disulfide-bond-cleaving mucolytic mechanism
See how your Anki deck covers Respiratory.
Upload your deck for a free audit →